サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1468253

麻酔・呼吸器市場レポート：製品タイプ、エンドユーザー、地域別、2024年～2032年

Anesthesia and Respiratory Devices Market Report by Product Type, End User, Region 2024-2032
出版日: | 発行: IMARC | ページ情報: 英文 138 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.58円
麻酔・呼吸器市場レポート：製品タイプ、エンドユーザー、地域別、2024年～2032年
出版日: 2024年04月08日
発行: IMARC
ページ情報: 英文 138 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の麻酔・呼吸器市場規模は2023年に468億米ドルに達しました。今後、IMARC Groupは、同市場が2032年までに812億米ドルに達し、2024～2032年の成長率（CAGR）は6.2％になると予測しています。呼吸器疾患の有病率の上昇、外科手術の増加、新興国市場の高齢化、ヘルスケアとインフラ開拓の進展、有利な政府のイニシアチブとヘルスケア支出などが市場を推進する主な要因です。

麻酔・呼吸器用機器は、外科手術中の患者ケアを容易にし、呼吸器疾患を管理するためにヘルスケア環境で使用される必須医療機器です。麻酔装置は、患者に全身麻酔を施し、一時的に感覚と意識を失わせ、痛みのない手術を可能にするように設計されています。これらの装置には通常、麻酔器、気化器、および患者の安全性と適切な投与量を確保するためのさまざまな監視装置が含まれます。一方、呼吸器は、呼吸器疾患の治療と管理に用いられる医療器具です。慢性閉塞性肺疾患（COPD）、喘息、急性呼吸窮迫症候群（ARDS）などの患者の呼吸と酸素供給を改善するのに役立ちます。一般的な呼吸器には、人工呼吸器、持続陽圧呼吸器（CPAP）、ネブライザー、酸素濃縮器などがあります。人工呼吸器は、自力で十分な呼吸ができない患者に機械的換気のサポートを提供する上で特に重要です。麻酔器も呼吸器も、現代のヘルスケアにおいて重要な役割を果たしており、患者の転帰を向上させ、医療全体を改善しています。これらの機器は、安全性、有効性、品質を確保するために厳しい規制要件が課されており、その継続的な開発と革新は、医療行為と患者の福祉の向上に大きく貢献しています。

慢性閉塞性肺疾患（COPD）、喘息、睡眠時無呼吸症候群を含む呼吸器疾患の罹患率の上昇は、呼吸器用機器の主要な原動力です。これらの疾患は継続的なモニタリングと管理を必要とするため、酸素濃縮器、ネブライザー、CPAPマシンなどの呼吸器機器の需要が増加しています。さらに、世界の人口増加とヘルスケアサービスへのアクセス向上により、外科手術が急増しています。麻酔装置は、手術中の安全かつ効果的な麻酔投与を確保するために極めて重要であり、麻酔装置、人工呼吸器、および関連機器の需要に拍車をかけています。この他にも、高齢化社会への人口動態の変化は、慢性疾患や呼吸器疾患の有病率の上昇に寄与しています。高齢者は医療介入、手術、呼吸器サポートを必要とすることが多く、麻酔・呼吸器機器の需要を牽引しています。このほか、特に新興国ではヘルスケア・インフラの拡大により、病院や専門クリニックなどの医療施設への投資が増加しています。このようなヘルスケア施設の増加は、より多くの患者のニーズに応えるため、麻酔・呼吸器機器の需要を強化しています。さらに、政府の支援政策、ヘルスケアへの投資、医療治療の保険適用が、麻酔・呼吸器市場の成長をさらに刺激し、これらの機器の採用率を高めています。さらに、医療技術の絶え間ない進歩により、より洗練された使いやすい麻酔・呼吸器機器が開発されています。患者モニタリング機能を向上させた先進的な人工呼吸器、精度と安全性を高めた麻酔器、携帯型呼吸器などの技術革新により、これらの機器の採用と需要が増加しています。

麻酔・呼吸器機器の市場動向と促進要因：

技術の進歩

技術の進歩は、機能を強化した革新的な機器を導入することで、麻酔・呼吸器市場に革命をもたらしました。例えば、先進的な麻酔器は現在、統合タッチスクリーンインターフェース、リアルタイムデータ監視、自動薬物送達システムを提供し、手術中の精度と患者の安全性を向上させています。同様に、呼吸器用機器も目覚ましい進歩を遂げており、携帯型酸素濃縮器によって、患者は酸素療法を継続的に受けながら移動能力を維持できるようになった。さらに、高度なアルゴリズムを搭載したスマート人工呼吸器は、変化する患者の呼吸ニーズに適応し、個別化されたケアを提供することができます。こうした技術的改良は、麻酔・呼吸器治療の効率と有効性を高めるだけでなく、患者の転帰の改善と回復時間の短縮にも貢献し、世界のヘルスケアプロバイダーによるこれらの機器の採用を促進しています。

呼吸器疾患の有病率の上昇

呼吸器疾患の有病率の上昇は、麻酔・呼吸器市場に大きな影響を与えています。COPD、喘息、睡眠時無呼吸症候群などの慢性呼吸器疾患は、世界中で数百万人に影響を及ぼしています。その結果、これらの慢性疾患を効果的に管理するために、ネブライザー、CPAPマシン、BiPAPマシンなどの呼吸器系機器の需要が急増しています。さらに、環境要因、汚染、ライフスタイルの変化が呼吸器疾患患者数の増加に寄与しており、市場の成長をさらに促進しています。メーカーは、患者の快適性を向上させ、より良い疾患管理を提供する先進的な呼吸器デバイスを開発するために研究開発に投資しており、このようなソリューションに対する需要の高まりに対応しています。

高齢化人口の拡大

世界人口の高齢化は、麻酔・呼吸器市場の主要な促進要因です。高齢者の増加に伴い、呼吸器疾患を含む加齢に関連した健康問題の有病率が上昇しています。高齢者は外科手術を必要とすることが多く、安全で正確な麻酔を提供するための麻酔器に対する需要が高まっています。さらに、高齢者は呼吸器疾患にかかりやすいため、その健康状態を管理するための人工呼吸器や酸素濃縮器などの呼吸器機器のニーズが高まっています。政府やヘルスケアプロバイダーは、高齢化社会の医療ニーズに対応するために医療施設の更新に投資しており、麻酔・呼吸器機器の需要をさらに押し上げています。この人口動態の変化は、今後数年間、市場の成長軌道を維持すると予想されます。

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査目的
  • 利害関係者
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要産業動向

第5章 麻酔・呼吸器デバイスの世界市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場予測

第6章 市場内訳：製品タイプ別

  • 麻酔機器
    • 市場動向
    • 主要セグメント
      • 麻酔デリバリー機器
      • 麻酔器具および付属品
      • 麻酔モニター
      • 麻酔情報管理システム
    • 市場予測
  • 呼吸器デバイス
    • 市場動向
    • 主要セグメント
      • 治療機器
      • マスク
      • 人工呼吸器
      • ネブライザー
      • 加湿器
      • 酸素濃縮器
      • 吸入器
      • 再利用可能な蘇生器
      • 一酸化窒素供給装置
      • カプノグラフ
      • ガス分析器
      • 酸素フード
    • 市場予測
  • モニタリング機器
    • 市場動向
    • 市場予測
  • 診断機器
    • 市場動向
    • 主要セグメント
      • スパイロメーター
      • 睡眠ポリグラフ（PSG）装置
      • ピークフローメーター
    • 市場予測
  • 消耗品とアクセサリー
    • 市場動向
    • 主要セグメント
      • 使い捨て蘇生器
      • 気管切開チューブ
      • 鼻カニューレ
      • 使い捨てマスク
      • その他
    • 市場予測

第7章 市場内訳：エンドユーザー別

  • 病院
    • 市場動向
    • 市場予測
  • クリニック
    • 市場動向
    • 市場予測
  • 在宅ケア
    • 市場動向
    • 市場予測
  • 外来サービスセンター
    • 市場動向
    • 市場予測

第8章 市場内訳：地域別

  • 北米
    • 米国
    • カナダ
  • アジア太平洋
    • 中国
    • 日本
    • インド
    • 韓国
    • オーストラリア
    • インドネシア
    • その他
  • 欧州
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • スペイン
    • ロシア
    • その他
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • その他
  • 中東・アフリカ
    • 市場動向
    • 市場内訳：国別
    • 市場予測

第9章 SWOT分析

  • 概要
  • 強み
  • 弱み
  • 機会
  • 脅威

第10章 バリューチェーン分析

第11章 ポーターのファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の程度
  • 新規参入業者の脅威
  • 代替品の脅威

第12章 価格分析

第13章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • 3M Company
    • Becton, Dickinson and Company
    • Dragerwerk AG & Co. KGaA
    • Fisher & Paykel Healthcare Corporation Limited
    • GE HealthCare（General Electric）
    • Getinge AB
    • Hamilton Medical（Hamilton Bonaduz AG）
    • ICU Medical Inc.
    • Koninklijke Philips N.V.
    • Masimo Corporation
    • Medtronic plc
    • SunMed LLC
    • Teleflex Incorporated
図表

List of Figures

  • Figure 1: Global: Anesthesia and Respiratory Devices Market: Major Drivers and Challenges
  • Figure 2: Global: Anesthesia and Respiratory Devices Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Anesthesia and Respiratory Devices Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 4: Global: Anesthesia and Respiratory Devices Market: Breakup by Product Type (in %), 2023
  • Figure 5: Global: Anesthesia and Respiratory Devices Market: Breakup by End User (in %), 2023
  • Figure 6: Global: Anesthesia and Respiratory Devices Market: Breakup by Region (in %), 2023
  • Figure 7: Global: Anesthesia and Respiratory Devices (Anesthesia Devices) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 8: Global: Anesthesia and Respiratory Devices (Anesthesia Devices) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 9: Global: Anesthesia and Respiratory Devices (Respiratory Devices) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 10: Global: Anesthesia and Respiratory Devices (Respiratory Devices) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 11: Global: Anesthesia and Respiratory Devices (Monitoring Devices) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 12: Global: Anesthesia and Respiratory Devices (Monitoring Devices) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 13: Global: Anesthesia and Respiratory Devices (Diagnostic Devices) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 14: Global: Anesthesia and Respiratory Devices (Diagnostic Devices) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 15: Global: Anesthesia and Respiratory Devices (Consumables and Accessories) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 16: Global: Anesthesia and Respiratory Devices (Consumables and Accessories) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 17: Global: Anesthesia and Respiratory Devices (Hospitals) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 18: Global: Anesthesia and Respiratory Devices (Hospitals) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 19: Global: Anesthesia and Respiratory Devices (Clinics) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 20: Global: Anesthesia and Respiratory Devices (Clinics) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 21: Global: Anesthesia and Respiratory Devices (Homecare Settings) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 22: Global: Anesthesia and Respiratory Devices (Homecare Settings) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 23: Global: Anesthesia and Respiratory Devices (Ambulatory Service Centers) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 24: Global: Anesthesia and Respiratory Devices (Ambulatory Service Centers) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 25: North America: Anesthesia and Respiratory Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 26: North America: Anesthesia and Respiratory Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 27: United States: Anesthesia and Respiratory Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 28: United States: Anesthesia and Respiratory Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 29: Canada: Anesthesia and Respiratory Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 30: Canada: Anesthesia and Respiratory Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 31: Asia-Pacific: Anesthesia and Respiratory Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 32: Asia-Pacific: Anesthesia and Respiratory Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 33: China: Anesthesia and Respiratory Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 34: China: Anesthesia and Respiratory Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 35: Japan: Anesthesia and Respiratory Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 36: Japan: Anesthesia and Respiratory Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 37: India: Anesthesia and Respiratory Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 38: India: Anesthesia and Respiratory Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 39: South Korea: Anesthesia and Respiratory Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 40: South Korea: Anesthesia and Respiratory Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 41: Australia: Anesthesia and Respiratory Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 42: Australia: Anesthesia and Respiratory Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 43: Indonesia: Anesthesia and Respiratory Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 44: Indonesia: Anesthesia and Respiratory Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 45: Others: Anesthesia and Respiratory Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 46: Others: Anesthesia and Respiratory Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 47: Europe: Anesthesia and Respiratory Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 48: Europe: Anesthesia and Respiratory Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 49: Germany: Anesthesia and Respiratory Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 50: Germany: Anesthesia and Respiratory Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 51: France: Anesthesia and Respiratory Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 52: France: Anesthesia and Respiratory Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 53: United Kingdom: Anesthesia and Respiratory Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 54: United Kingdom: Anesthesia and Respiratory Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 55: Italy: Anesthesia and Respiratory Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 56: Italy: Anesthesia and Respiratory Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 57: Spain: Anesthesia and Respiratory Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 58: Spain: Anesthesia and Respiratory Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 59: Russia: Anesthesia and Respiratory Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 60: Russia: Anesthesia and Respiratory Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 61: Others: Anesthesia and Respiratory Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 62: Others: Anesthesia and Respiratory Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 63: Latin America: Anesthesia and Respiratory Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 64: Latin America: Anesthesia and Respiratory Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 65: Brazil: Anesthesia and Respiratory Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 66: Brazil: Anesthesia and Respiratory Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 67: Mexico: Anesthesia and Respiratory Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 68: Mexico: Anesthesia and Respiratory Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 69: Others: Anesthesia and Respiratory Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 70: Others: Anesthesia and Respiratory Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 71: Middle East and Africa: Anesthesia and Respiratory Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 72: Middle East and Africa: Anesthesia and Respiratory Devices Market: Breakup by Country (in %), 2023
  • Figure 73: Middle East and Africa: Anesthesia and Respiratory Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 74: Global: Anesthesia and Respiratory Devices Industry: SWOT Analysis
  • Figure 75: Global: Anesthesia and Respiratory Devices Industry: Value Chain Analysis
  • Figure 76: Global: Anesthesia and Respiratory Devices Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Anesthesia and Respiratory Devices Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Anesthesia and Respiratory Devices Market Forecast: Breakup by Product Type (in Million US$), 2024-2032
  • Table 3: Global: Anesthesia and Respiratory Devices Market Forecast: Breakup by End User (in Million US$), 2024-2032
  • Table 4: Global: Anesthesia and Respiratory Devices Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 5: Global: Anesthesia and Respiratory Devices Market: Competitive Structure
  • Table 6: Global: Anesthesia and Respiratory Devices Market: Key Players
目次
Product Code: SR112024A6105

The global anesthesia and respiratory devices market size reached US$ 46.8 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 81.2 Billion by 2032, exhibiting a growth rate (CAGR) of 6.2% during 2024-2032. The rising prevalence of respiratory disorders, increasing surgical procedures, expanding aging population, growing healthcare and infrastructure development, and favorable government initiatives and healthcare spending are some of the major factors propelling the market.

Anesthesia and respiratory devices are essential medical equipment used in healthcare settings to facilitate patient care during surgical procedures and manage respiratory conditions. Anesthesia devices are designed to administer general anesthesia to patients, inducing temporary loss of sensation and consciousness, enabling painless surgery. These devices typically include anesthesia machines, vaporizers, and various monitoring equipment to ensure patient safety and appropriate dosage administration. On the other hand, respiratory devices are medical tools utilized in the treatment and management of respiratory disorders. They aid in improving breathing and oxygenation for patients with conditions such as chronic obstructive pulmonary disease (COPD), asthma, or acute respiratory distress syndrome (ARDS). Some common respiratory devices include ventilators, continuous positive airway pressure (CPAP) machines, nebulizers, and oxygen concentrators. Ventilators are especially crucial in providing mechanical ventilation support to patients who are unable to breathe adequately on their own. Both anesthesia and respiratory devices play vital roles in modern healthcare, enhancing patient outcomes and improving overall medical care. These devices are subject to stringent regulatory requirements to ensure their safety, efficacy, and quality, and their continuous development and innovation contribute significantly to advancing medical practices and patient well-being.

The rising incidence of respiratory conditions, including chronic obstructive pulmonary disease (COPD), asthma, and sleep apnea, is a major driver for respiratory devices. These conditions require ongoing monitoring and management, leading to an increased demand for respiratory equipment like oxygen concentrators, nebulizers, and CPAP machines. Additionally, the growing global population, coupled with improved access to healthcare services, has led to a surge in surgical procedures. Anesthesia devices are crucial for ensuring safe and effective anesthesia administration during surgeries, fueling the demand for anesthesia machines, ventilators, and associated equipment. Other than this, the demographic shift towards an aging population has contributed to the rising prevalence of chronic diseases and respiratory disorders. Older adults often require medical interventions, surgeries, and respiratory support, driving the demand for anesthesia and respiratory devices. Besides this, expanding healthcare infrastructure, particularly in emerging economies, has led to increased investments in medical facilities, including hospitals and specialty clinics. This growth in healthcare facilities has bolstered the demand for anesthesia and respiratory equipment to cater to the needs of a larger patient population. Moreover, supportive government policies, investments in healthcare, and insurance coverage for medical treatments have further stimulated the growth of the anesthesia and respiratory market, encouraging higher adoption rates of these devices. Moreover, continuous advancements in medical technology have led to the development of more sophisticated and user-friendly anesthesia and respiratory devices. Innovations such as advanced ventilators with improved patient monitoring capabilities, anesthesia machines with enhanced precision and safety features, and portable respiratory devices have increased their adoption and demand.

Anesthesia and Respiratory Devices Market Trends/Drivers:

Technological Advancements

Technological advancements have revolutionized the anesthesia and respiratory market by introducing innovative devices with enhanced capabilities. For instance, advanced anesthesia machines now offer integrated touchscreen interfaces, real-time data monitoring, and automated drug delivery systems, improving precision and patient safety during surgery. Similarly, respiratory devices have seen remarkable progress, with portable oxygen concentrators enabling patients to maintain mobility while receiving continuous oxygen therapy. Additionally, smart ventilators equipped with advanced algorithms can adapt to patients' changing respiratory needs, providing personalized care. These technological improvements not only enhance the efficiency and efficacy of anesthesia and respiratory treatments but also contribute to better patient outcomes and reduced recovery times, driving the adoption of these devices by healthcare providers globally.

Rising Prevalence of Respiratory Disorders

The escalating prevalence of respiratory disorders has significantly impacted the anesthesia and respiratory market. Chronic respiratory conditions like COPD, asthma, and sleep apnea affect millions of people worldwide. Consequently, the demand for respiratory devices such as nebulizers, CPAP machines, and BiPAP machines has surged to manage these chronic conditions effectively. Moreover, environmental factors, pollution, and lifestyle changes have contributed to an increase in the number of respiratory disorder cases, further fueling the market's growth. Manufacturers are investing in research and development to create advanced respiratory devices that offer improved patient comfort and better disease management, catering to the escalating demand for such solutions.

Expanding Aging Population

The aging global population is a key driver of the anesthesia and respiratory market. With a higher number of elderly individuals, the prevalence of age-related health issues, including respiratory diseases, has risen. Older adults often require surgical interventions, leading to an increased demand for anesthesia machines to provide safe and precise anesthesia delivery. Furthermore, as the elderly are more susceptible to respiratory illnesses, there is a growing need for respiratory devices like ventilators and oxygen concentrators to manage their health conditions. Governments and healthcare providers are investing in updating their medical facilities to accommodate the aging population's healthcare needs, further propelling the demand for anesthesia and respiratory equipment. This demographic shift is expected to sustain the market's growth trajectory in the coming years.

Anesthesia and Respiratory Devices Industry Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the global anesthesia and respiratory devices market report, along with forecasts at the global, regional and country levels from 2024-2032. Our report has categorized the market based on product type and end user.

Breakup by Product Type:

Anesthesia Devices

Anesthesia Delivery Machines

Anesthesia Disposables and Accessories

Anesthesia Monitors

Anesthesia Information Management Systems

Respiratory Devices

Therapeutic Devices

Masks

Ventilators

Nebulizers

Humidifiers

Oxygen Concentrators

Inhalers

Reusable Resuscitators

Nitric Oxide Delivery Units

Capnographs

Gas Analyzers

Oxygen Hoods

Monitoring Devices

Diagnostic Devices

Spirometers

Polysomnography (PSG) Devices

Peak Flow Meters

Consumables and Accessories

Disposable Resuscitators

Tracheostomy Tubes

Nasal Cannulas

Disposable Masks

Others

Respiratory devices dominate the market

The report has provided a detailed breakup and analysis of the market based on the product type. This includes anesthesia devices (anesthesia delivery machines, anesthesia disposables and accessories, anesthesia monitors, and anesthesia information management systems), respiratory devices (therapeutic devices, masks, ventilators, nebulizers, humidifiers, oxygen concentrators, inhalers, reusable resuscitators, nitric oxide delivery units, capnographs, gas analyzers, and oxygen hoods), monitoring devices, diagnostic devices (spirometers, polysomnography (PSG) devices, and peak flow meters), and consumables and accessories (disposable resuscitators, tracheostomy tubes, nasal cannulas, disposable masks, and others). According to the report, respiratory devices represented the largest segment.

The rising prevalence of respiratory disorders globally has significantly increased the demand for respiratory devices. Conditions such as chronic obstructive pulmonary disease (COPD), asthma, and sleep apnea affect a large portion of the population, necessitating continuous monitoring and treatment, thereby boosting the market for respiratory devices. Additionally, advancements in medical technology have led to the development of more sophisticated and efficient respiratory devices. These innovations have improved patient comfort, ease of use, and treatment outcomes, driving healthcare providers to adopt the latest respiratory equipment, further contributing to the segment's growth. Other than this, with the aging population on the rise, the incidence of respiratory diseases is also increasing. Older adults are more susceptible to respiratory conditions, requiring respiratory devices for proper disease management and oxygen support. This demographic trend has significantly expanded the market for respiratory devices. Moreover, the ongoing COVID-19 pandemic has further accelerated the demand for respiratory devices like ventilators to provide life-saving respiratory support for critically ill patients, underscoring the critical role these devices play in managing respiratory distress.

Breakup by End User:

Hospitals

Clinics

Homecare Settings

Ambulatory Service Centers

Hospitals hold the largest share in the market

A detailed breakup and analysis of the market based on the end user has also been provided in the report. This includes hospitals, clinics, homecare settings, and ambulatory service centers. According to the report, hospitals accounted for the largest market share.

Hospitals serve as primary centers for providing advanced medical care, including surgeries, critical care, and specialized treatments. These medical facilities require a wide array of anesthesia and respiratory devices to cater to the diverse needs of patients across various medical disciplines. From anesthesia machines for surgical procedures to ventilators for patients in intensive care units, hospitals rely heavily on these devices to ensure optimal patient outcomes. Additionally, hospitals typically have a high patient throughput, admitting a large number of individuals requiring medical attention daily. This consistent flow of patients necessitates a substantial demand for anesthesia and respiratory devices to support their medical needs, contributing to the segment's size. Other than this, hospitals often have well-established budgets for medical equipment procurement, allowing them to invest in modern and technologically advanced anesthesia and respiratory devices. These devices play a critical role in enhancing patient care, leading hospitals to prioritize their acquisition. Furthermore, the ongoing pandemic situations, like COVID-19, have emphasized the need for well-equipped hospitals with an adequate supply of respiratory devices like ventilators to manage respiratory distress in critically ill patients. This further reinforces the hospitals' significance as the largest end-user segment in the anesthesia and respiratory market.

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

North America exhibits a clear dominance in the market

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for anesthesia and respiratory devices.

North America has a well-established and advanced healthcare infrastructure, with a high number of hospitals, specialty clinics, and medical facilities. This extensive healthcare network leads to a significant demand for anesthesia and respiratory devices to support the diverse medical needs of patients. Additionally, the region has a substantial elderly population, and with aging comes an increased prevalence of respiratory conditions and the need for surgical interventions, further driving the demand for these devices. Moreover, the region's strong emphasis on research and development in the medical technology sector has led to continuous innovation and the introduction of cutting-edge anesthesia and respiratory devices. This culture of technological advancement and early adoption of new medical equipment contributes to the market's growth. Besides this, factors such as favorable government initiatives, high healthcare expenditure, and insurance coverage facilitate greater accessibility to advanced medical treatments, including anesthesia and respiratory care, further propelling the market in North America. Furthermore, the outbreak of global health crises, such as the COVID-19 pandemic, has highlighted the critical importance of having a robust supply of respiratory devices like ventilators, elevating the demand for these devices in the region.

Competitive Landscape:

Leading companies in the anesthesia and respiratory devices market invest significantly in research and development to introduce innovative products with advanced features. These innovations aim to improve patient outcomes, enhance user experience, and address specific medical challenges. For example, companies may develop anesthesia machines with integrated patient monitoring systems, smart ventilation modes, or respiratory devices with better portability and user-friendly interfaces. By continuously introducing cutting-edge technologies, key players can attract more customers, gain a competitive edge, and drive market growth. Additionally, collaborations and partnerships with other healthcare companies, research institutions, or technology firms are common strategies employed by key players in the anesthesia and respiratory devices market. These partnerships facilitate the exchange of knowledge, expertise, and resources, leading to the development of innovative solutions. For instance, a medical device manufacturer may collaborate with a software company to integrate artificial intelligence algorithms into their devices for enhanced diagnostics and personalized treatments. Such strategic alliances enable companies to leverage each other's strengths and expand their product portfolio, leading to increased market presence and revenue growth. Other than this, in order to tap into emerging markets and cater to the growing demand for anesthesia and respiratory devices, key players often focus on expanding their geographic reach. This expansion may involve establishing new distribution channels, setting up local manufacturing facilities, or acquiring regional companies to gain a foothold in specific markets. By penetrating new regions, companies can access a larger customer base, better understand local requirements, and adapt their products to meet diverse healthcare needs, ultimately driving market growth.

The market research report has provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

3M Company

Becton, Dickinson and Company

Dragerwerk AG & Co. KGaA

Fisher & Paykel Healthcare Corporation Limited

GE HealthCare (General Electric)

Getinge AB

Hamilton Medical (Hamilton Bonaduz AG)

ICU Medical Inc.

Koninklijke Philips N.V.

Masimo Corporation

Medtronic plc

SunMed LLC

Teleflex Incorporated

Recent Developments:

GE Healthcare is the only manufacturer approved to offer general anesthesia delivery with end-tidal concentration control in the United States. It has developed the Aisys CS2 anesthesia machine, which is designed to support system interoperability by simplifying connections to other medical devices and hospital networks.

Medtronic plc, a global leader in medical technology, has recently made advancements in anesthesia and respiratory devices by introducing the Medtronic RespArray patient monitor. This device aims to reduce the risk of respiratory compromise and improve workflow in healthcare setting.

Key Questions Answered in This Report

  • 1. What was the size of the anesthesia and respiratory devices market in 2023?
  • 2. What is the expected growth rate of the global anesthesia and respiratory devices market during 2024-2032?
  • 3. What are the key factors driving the global anesthesia and respiratory devices market?
  • 4. What has been the impact of COVID-19 on the global anesthesia and respiratory devices market?
  • 5. What is the breakup of the global anesthesia and respiratory devices market based on the product type?
  • 6. What is the breakup of the global anesthesia and respiratory devices market based on the end user?
  • 7. What are the key regions in the global anesthesia and respiratory devices market?
  • 8. Who are the key players/companies in the global anesthesia and respiratory devices market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Anesthesia and Respiratory Devices Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product Type

  • 6.1 Anesthesia Devices
    • 6.1.1 Market Trends
    • 6.1.2 Key Segments
      • 6.1.2.1 Anesthesia Delivery Machines
      • 6.1.2.2 Anesthesia Disposables and Accessories
      • 6.1.2.3 Anesthesia Monitors
      • 6.1.2.4 Anesthesia Information Management Systems
    • 6.1.3 Market Forecast
  • 6.2 Respiratory Devices
    • 6.2.1 Market Trends
    • 6.2.2 Key Segments
      • 6.2.2.1 Therapeutic Devices
      • 6.2.2.2 Masks
      • 6.2.2.3 Ventilators
      • 6.2.2.4 Nebulizers
      • 6.2.2.5 Humidifiers
      • 6.2.2.6 Oxygen Concentrators
      • 6.2.2.7 Inhalers
      • 6.2.2.8 Reusable Resuscitators
      • 6.2.2.9 Nitric Oxide Delivery Units
      • 6.2.2.10 Capnographs
      • 6.2.2.11 Gas Analyzers
      • 6.2.2.12 Oxygen Hoods
    • 6.2.3 Market Forecast
  • 6.3 Monitoring Devices
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Diagnostic Devices
    • 6.4.1 Market Trends
    • 6.4.2 Key Segments
      • 6.4.2.1 Spirometers
      • 6.4.2.2 Polysomnography (PSG) Devices
      • 6.4.2.3 Peak Flow Meters
    • 6.4.3 Market Forecast
  • 6.5 Consumables and Accessories
    • 6.5.1 Market Trends
    • 6.5.2 Key Segments
      • 6.5.2.1 Disposable Resuscitators
      • 6.5.2.2 Tracheostomy Tubes
      • 6.5.2.3 Nasal Cannulas
      • 6.5.2.4 Disposable Masks
      • 6.5.2.5 Others
    • 6.5.3 Market Forecast

7 Market Breakup by End User

  • 7.1 Hospitals
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Clinics
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Homecare Settings
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Ambulatory Service Centers
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast

8 Market Breakup by Region

  • 8.1 North America
    • 8.1.1 United States
      • 8.1.1.1 Market Trends
      • 8.1.1.2 Market Forecast
    • 8.1.2 Canada
      • 8.1.2.1 Market Trends
      • 8.1.2.2 Market Forecast
  • 8.2 Asia-Pacific
    • 8.2.1 China
      • 8.2.1.1 Market Trends
      • 8.2.1.2 Market Forecast
    • 8.2.2 Japan
      • 8.2.2.1 Market Trends
      • 8.2.2.2 Market Forecast
    • 8.2.3 India
      • 8.2.3.1 Market Trends
      • 8.2.3.2 Market Forecast
    • 8.2.4 South Korea
      • 8.2.4.1 Market Trends
      • 8.2.4.2 Market Forecast
    • 8.2.5 Australia
      • 8.2.5.1 Market Trends
      • 8.2.5.2 Market Forecast
    • 8.2.6 Indonesia
      • 8.2.6.1 Market Trends
      • 8.2.6.2 Market Forecast
    • 8.2.7 Others
      • 8.2.7.1 Market Trends
      • 8.2.7.2 Market Forecast
  • 8.3 Europe
    • 8.3.1 Germany
      • 8.3.1.1 Market Trends
      • 8.3.1.2 Market Forecast
    • 8.3.2 France
      • 8.3.2.1 Market Trends
      • 8.3.2.2 Market Forecast
    • 8.3.3 United Kingdom
      • 8.3.3.1 Market Trends
      • 8.3.3.2 Market Forecast
    • 8.3.4 Italy
      • 8.3.4.1 Market Trends
      • 8.3.4.2 Market Forecast
    • 8.3.5 Spain
      • 8.3.5.1 Market Trends
      • 8.3.5.2 Market Forecast
    • 8.3.6 Russia
      • 8.3.6.1 Market Trends
      • 8.3.6.2 Market Forecast
    • 8.3.7 Others
      • 8.3.7.1 Market Trends
      • 8.3.7.2 Market Forecast
  • 8.4 Latin America
    • 8.4.1 Brazil
      • 8.4.1.1 Market Trends
      • 8.4.1.2 Market Forecast
    • 8.4.2 Mexico
      • 8.4.2.1 Market Trends
      • 8.4.2.2 Market Forecast
    • 8.4.3 Others
      • 8.4.3.1 Market Trends
      • 8.4.3.2 Market Forecast
  • 8.5 Middle East and Africa
    • 8.5.1 Market Trends
    • 8.5.2 Market Breakup by Country
    • 8.5.3 Market Forecast

9 SWOT Analysis

  • 9.1 Overview
  • 9.2 Strengths
  • 9.3 Weaknesses
  • 9.4 Opportunities
  • 9.5 Threats

10 Value Chain Analysis

11 Porters Five Forces Analysis

  • 11.1 Overview
  • 11.2 Bargaining Power of Buyers
  • 11.3 Bargaining Power of Suppliers
  • 11.4 Degree of Competition
  • 11.5 Threat of New Entrants
  • 11.6 Threat of Substitutes

12 Price Analysis

13 Competitive Landscape

  • 13.1 Market Structure
  • 13.2 Key Players
  • 13.3 Profiles of Key Players
    • 13.3.1 3M Company
      • 13.3.1.1 Company Overview
      • 13.3.1.2 Product Portfolio
    • 13.3.2 Becton, Dickinson and Company
      • 13.3.2.1 Company Overview
      • 13.3.2.2 Product Portfolio
    • 13.3.3 Dragerwerk AG & Co. KGaA
      • 13.3.3.1 Company Overview
      • 13.3.3.2 Product Portfolio
    • 13.3.4 Fisher & Paykel Healthcare Corporation Limited
      • 13.3.4.1 Company Overview
      • 13.3.4.2 Product Portfolio
    • 13.3.5 GE HealthCare (General Electric)
      • 13.3.5.1 Company Overview
      • 13.3.5.2 Product Portfolio
    • 13.3.6 Getinge AB
      • 13.3.6.1 Company Overview
      • 13.3.6.2 Product Portfolio
    • 13.3.7 Hamilton Medical (Hamilton Bonaduz AG)
      • 13.3.7.1 Company Overview
      • 13.3.7.2 Product Portfolio
    • 13.3.8 ICU Medical Inc.
      • 13.3.8.1 Company Overview
      • 13.3.8.2 Product Portfolio
    • 13.3.9 Koninklijke Philips N.V.
      • 13.3.9.1 Company Overview
      • 13.3.9.2 Product Portfolio
    • 13.3.10 Masimo Corporation
      • 13.3.10.1 Company Overview
      • 13.3.10.2 Product Portfolio
    • 13.3.11 Medtronic plc
      • 13.3.11.1 Company Overview
      • 13.3.11.2 Product Portfolio
    • 13.3.12 SunMed LLC
      • 13.3.12.1 Company Overview
      • 13.3.12.2 Product Portfolio
    • 13.3.13 Teleflex Incorporated
      • 13.3.13.1 Company Overview
      • 13.3.13.2 Product Portfolio